These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11672511)

  • 1. Bleeding diathesis in multiple myeloma.
    Saif MW; Allegra CJ; Greenberg B
    J Hematother Stem Cell Res; 2001 Oct; 10(5):657-60. PubMed ID: 11672511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increased thrombin time in a patient with multiple myeloma].
    Bohler A; Redondo M; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):491-4. PubMed ID: 10517116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired dysfibrinogenemia secondary to multiple myeloma.
    Kotlín R; Sobotková A; Riedel T; Salaj P; Suttnar J; Reicheltová Z; Májek P; Khaznadar T; Dyr JE
    Acta Haematol; 2008; 120(2):75-81. PubMed ID: 18841003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-like anticoagulant associated with plasma cell myeloma.
    Chapman GS; George CB; Danley DL
    Am J Clin Pathol; 1985 Jun; 83(6):764-6. PubMed ID: 3923825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disorders in the conversion of fibrinogen to fibrin in patients with multiple myeloma].
    Lopaciuk S; Snigurowicz J; Rostkowska J; Pniejnia-Olszyński W; Powiertowska-Rezmer M
    Acta Haematol Pol; 1978; 9(3):157-64. PubMed ID: 102100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a monoclonal thrombin inhibitor associated with multiple myeloma and a severe bleeding disorder.
    Colwell NS; Tollefsen DM; Blinder MA
    Br J Haematol; 1997 Apr; 97(1):219-26. PubMed ID: 9136969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic abnormalities in multiple myeloma and related disorders.
    Glaspy JA
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1301-14. PubMed ID: 1452513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of serum monoclonal protein concentration on haemostasis in patients with multiple myeloma.
    Huang H; Li H; Li D
    Blood Coagul Fibrinolysis; 2015 Jul; 26(5):555-9. PubMed ID: 25828972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic abnormalities in Noonan syndrome.
    Artoni A; Selicorni A; Passamonti SM; Lecchi A; Bucciarelli P; Cerutti M; Cianci P; Gianniello F; Martinelli I
    Pediatrics; 2014 May; 133(5):e1299-304. PubMed ID: 24753526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of fibrin monomer polymerisation by myeloma immunoglobulin.
    O'Kane MJ; Wisdom GB; Desai ZR; Archbold GP
    J Clin Pathol; 1994 Mar; 47(3):266-8. PubMed ID: 8163700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a myeloma patient with a life-threatening hemorrhagic diathesis: presence of a lambda dimer protein inhibiting shear-induced platelet aggregation by binding to the A1 domain of von Willebrand factor.
    Shinagawa A; Kojima H; Berndt MC; Kaneko S; Suzukawa K; Hasegawa Y; Shigeta O; Nagasawa T
    Thromb Haemost; 2005 May; 93(5):889-96. PubMed ID: 15886805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemorrhagic diathesis in multiple myeloma.
    Wallace MR; Simon SR; Ershler WB; Burns SL
    Acta Haematol; 1984; 72(5):340-2. PubMed ID: 6441414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-like anticoagulant associated with multiple myeloma and neutralized with protamine sulfate.
    Torjemane L; Guermazi S; Ladeb S; Ben Romdhane N; Lakhal A; Abdelkefi A; Ben Othman T; Ben Abdelhadhim A
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):279-81. PubMed ID: 17413766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
    Al-Mondhiry H; Galanakis D
    J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anemia and hemostatic abnormalities associated with multiple myeloma].
    Aoki S; Shibata A
    Nihon Rinsho; 1995 Mar; 53(3):690-4. PubMed ID: 7699906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A patient with isolated prolongation of aPTT without hemorrhagic diathesis anamnesis: severe, hereditary factor XII deficiency].
    Zeerleder S; Asmis L; Redondo M; Sulzer I; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):509-12. PubMed ID: 10517121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesis.
    Daskalakis M; Colucci G; Keller P; Rochat S; Silzle T; Biasiutti FD; Barizzi G; Alberio L
    Cytometry B Clin Cytom; 2014 Nov; 86(6):397-409. PubMed ID: 24677789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Passovoy defect: further characterization of a hereditary hemorrhagic diathesis.
    Hougie C; Mc Pherson RA; Brown JE; Lakin-Thomas PL; Melaragno A; Aronson L; Baugh RF
    N Engl J Med; 1978 May; 298(19):1045-8. PubMed ID: 643012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding in uremic patients after carbenicillin.
    Andrassy K; Weischedel E; Ritz E; Andrassy T
    Thromb Haemost; 1976 Aug; 36(1):115-26. PubMed ID: 1036800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.